The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(1H-indol-3-yl)-1-(2,2,2-trifluoroethyl)-1H-benzo[d][1,2,3]triazole ID: ALA4871568
PubChem CID: 164622020
Max Phase: Preclinical
Molecular Formula: C16H11F3N4
Molecular Weight: 316.29
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: FC(F)(F)Cn1nnc2ccc(-c3c[nH]c4ccccc34)cc21
Standard InChI: InChI=1S/C16H11F3N4/c17-16(18,19)9-23-15-7-10(5-6-14(15)21-22-23)12-8-20-13-4-2-1-3-11(12)13/h1-8,20H,9H2
Standard InChI Key: SSECOCRNMXVUGQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
17.0124 -15.2377 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
17.4252 -15.9476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8336 -15.2352 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
11.7818 -18.2712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7807 -19.0907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4887 -19.4997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4869 -17.8623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1956 -18.2676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2003 -19.0862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9804 -19.3347 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.4577 -18.6695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9726 -18.0102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2206 -17.2315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0207 -17.0617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9163 -15.8569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6719 -16.6345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7207 -15.6758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2659 -16.2815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0104 -15.9502 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.9254 -15.1397 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.1283 -14.9702 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7180 -16.3590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1334 -16.3593 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 8 1 0
12 13 1 0
13 14 2 0
14 18 1 0
17 15 1 0
15 16 2 0
16 13 1 0
17 18 2 0
18 19 1 0
19 20 1 0
20 21 2 0
21 17 1 0
19 22 1 0
22 2 1 0
2 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 316.29Molecular Weight (Monoisotopic): 316.0936AlogP: 4.14#Rotatable Bonds: 2Polar Surface Area: 46.50Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 0.29CX LogP: 4.13CX LogD: 4.13Aromatic Rings: 4Heavy Atoms: 23QED Weighted: 0.60Np Likeness Score: -1.34
References 1. Kozlova A, Thabault L, Liberelle M, Klaessens S, Prévost JRC, Mathieu C, Pilotte L, Stroobant V, Van den Eynde B, Frédérick R.. (2021) Rational Design of Original Fused-Cycle Selective Inhibitors of Tryptophan 2,3-Dioxygenase., 64 (15.0): [PMID:34338527 ] [10.1021/acs.jmedchem.1c00323 ]